| Literature DB >> 30653654 |
R J Meinds1, A F W van der Steeg2,3, C E J Sloots4, M J Witvliet5, I de Blaauw6, W G van Gemert7, M Trzpis8, P M A Broens1,8.
Abstract
BACKGROUND: It is unclear whether functional outcomes improve or deteriorate with age following surgery for Hirschsprung's disease. The aim of this cross-sectional study was to determine the long-term functional outcomes and quality of life (QoL) in patients with Hirschsprung's disease.Entities:
Mesh:
Year: 2019 PMID: 30653654 PMCID: PMC6590339 DOI: 10.1002/bjs.11059
Source DB: PubMed Journal: Br J Surg ISSN: 0007-1323 Impact factor: 6.939
Patient characteristics and dropout analysis
| Non‐responders ( | Responders ( |
| |
|---|---|---|---|
| Age (years) | 22 (8–50) | 18 (8–45) | 0·004 |
| Sex ratio (M : F) | 224 : 49 | 274 : 72 | 0·373 |
| Co‐morbidities | 26 (9·5) | 33 (9·5) | 1·000 |
| Length of aganglionosis | 0·804 | ||
| Ultrashort | 5 (1·8) | 10 (2·9) | |
| Rectosigmoid | 222 (81·3) | 282 (81·5) | |
| Long segment | 23 (8·4) | 29 (8·4) | |
| Total colonic | 23 (8·4) | 25 (7·2) | |
| Preoperative enterocolitis | 30 (11·0) | 46 (13·3) | 0·395 |
| Primary surgical treatment | 0·443 | ||
| Surgical reconstruction | 265 (97·1) | 337 (97·4) | |
| Sphincterectomy | 3 (1·1) | 4 (1·2) | |
| Other | 2 (0·7) | 0 (0·0) | |
| None/conservative | 3 (1·1) | 5 (1·4) | |
| Surgical reconstruction | 0·166 | ||
| Duhamel | 149 (56·2) | 210 (62·3) | |
| Soave | 1 (0·4) | 1 (0·3) | |
| Rehbein | 80 (30·2) | 73 (21·7) | |
| Swenson | 0 (0) | 1 (0·3) | |
| Transanal endorectal pull‐through | 35 (13·2) | 52 (15·4) | |
| Postoperative complication | 26 of 270 (9·6) | 36 of 341 (10·6) | 0·706 |
| Postoperative enterocolitis | 24 of 270 (8·9) | 47 of 341 (13·8) | 0·061 |
| Redo pull‐through | 15 of 270 (5·6) | 23 of 341 (6·7) | 0·546 |
Values in parentheses are percentages unless indicated otherwise;
values are median (range).
χ2 test, except
Mann–Whitney U test.
Functional outcomes in children and adults
| Children (8–17 years) | Adults (≥ 18 years) | ||||||
|---|---|---|---|---|---|---|---|
| Patients ( | Controls ( |
| Patients ( | Controls ( |
|
| |
| Constipation | |||||||
| Prevalence (Rome IV) | 38 (22·0) | 21 (14·3) | 0·077 | 38 (22·0) | 28 (19·0) | 0·520 | 1·000 |
| Symptoms | |||||||
| Straining | 64 (37·0) | 32 (21·8) | 0·003 | 87 (50·3) | 53 (36·1) | 0·011 | 0·013 |
| Lumpy or hard stools | 5 (2·9) | 14 (9·5) | 0·012 | 11 (6·4) | 9 (6·1) | 0·931 | 0·125 |
| Incomplete evacuation | 68 (39·3) | 13 (8·8) | < 0·001 | 82 (47·4) | 40 (27·2) | < 0·001 | 0·129 |
| Anorectal obstruction | 39 (22·5) | 17 (11·6) | 0·010 | 44 (25·4) | 25 (17·0) | 0·068 | 0·529 |
| Manual manoeuvres | 0 (0) | 3 (2·0) | 0·059 | 10 (5·8) | 7 (4·8) | 0·686 | 0·001 |
| < 3 bowel movements per week | 12 (6·9) | 12 (8·2) | 0·678 | 18 (10·4) | 19 (12·9) | 0·482 | 0·252 |
| Laxative use | 53 (30·6) | 6 (4·1) | < 0·001 | 9 (5·2) | 6 (4·1) | 0·636 | < 0·001 |
| Bowel management for constipation | 31 (17·9) | 1 (0·7) | < 0·001 | 14 (8·1) | 1 (0·7) | 0·002 | 0·007 |
| Faecal incontinence | |||||||
| Prevalence (Rome IV) | 65 (37·6) | 9 (6·1) | < 0·001 | 29 (16·8) | 9 (6·1) | 0·003 | < 0·001 |
| Subtypes | |||||||
| Soiling | 60 (34·7) | 6 (4·1) | < 0·001 | 29 (16·8) | 6 (4·1) | < 0·001 | < 0·001 |
| Urge incontinence | 7 (4·0) | 2 (1·4) | 0·148 | 2 (1·2) | 3 (2·0) | 0·525 | 0·091 |
| Incontinence to solid stool | 12 (6·9) | 3 (2·0) | 0·039 | 2 (1·2) | 3 (2·0) | 0·525 | 0·006 |
| Incontinence to liquid stool | 15 (8·7) | 2 (1·4) | 0·004 | 5 (2·9) | 5 (3·4) | 0·793 | 0·021 |
| Bowel management for faecal incontinence | 19 (11·0) | 1 (0·7) | < 0·001 | 3 (1·7) | 0 (0·0) | 0·109 | 0·017 |
Values in parentheses are percentages.
Respondents often had various types of faecal incontinence.
χ2 test.
Prevalence and likelihood of faecal incontinence
| Likelihood of faecal incontinence | |||||||
|---|---|---|---|---|---|---|---|
| Univariable analysis | Multivariable analysis | ||||||
| Total no. of patients | Prevalence of faecal incontinence (%) |
| Odds ratio |
| Odds ratio |
| |
| Overall | 346 | 27·2 (22·5, 31·9) | |||||
| Sex | 0·175 | ||||||
| Men | 274 (79·2) | 28·8 (23·4, 34·2) | 1·00 (reference) | ||||
| Women | 72 (20·8) | 21 (11, 30) | 0·65 (0·35, 1·21) | 0·177 | |||
| Patient group | < 0·001 | ||||||
| Children (8–17 years) | 173 (50·0) | 37·6 (30·3, 44·9) | 1·00 (reference) | 1·00 (reference) | |||
| Adults (≥ 18 years) | 173 (50·0) | 16·8 (11·1, 22·4) | 0·33 (0·20, 0·55) | < 0·001 | 0·35 (0·21, 0·58) | < 0·001 | |
| Length of aganglionosis | 0·482 | ||||||
| Ultrashort | 10 (2·9) | 20 (–10, 50) | 0·70 (0·15, 3·38) | 0·660 | |||
| Rectosigmoid | 282 (81·5) | 26·2 (21·1, 31·4) | 1·00 (reference) | ||||
| Long segment | 29 (8·4) | 28 (10, 45) | 1·07 (0·45, 2·52) | 0·876 | |||
| Total colonic | 25 (7·2) | 40 (19, 61) | 1·87 (0·81, 4·35) | 0·144 | |||
| Postoperative complication | 0·777 | ||||||
| No | 305 (89·4) | 27·2 (22·2, 32·2) | 1·00 (reference) | ||||
| Yes | 36 (10·6) | 25 (10, 40) | 0·89 (0·40, 1·97) | 0·769 | |||
| Redo pull‐through | 0·001 | ||||||
| No | 323 (93·4) | 25·1 (20·3, 29·8) | 1·00 (reference) | 1·00 (reference) | |||
| Yes | 23 (6·6) | 57 (35, 78) | 3·88 (1·64, 9·20) | 0·002 | 3·54 (1·46, 8·62) | 0·005 | |
Values in parentheses are 95 per cent confidence intervals unless indicated otherwise;
values in parentheses are percentages.
χ2 test.
Logistic regression analysis; variables with P < 0·100 in univariable analysis were subsequently included in the multivariable analysis.
Figure 1Quality‐of‐life scores of children and adults with Hirschsprung's disease compared with reference data from healthy controls. a Child Health Questionnaire Child Form (CHQ‐CF87) scores in children; b WHO Quality of Life (WHOQOL‐100) score in adults. Values are mean with 95 per cent confidence interval. QoL, quality of life. *P < 0·050, †P < 0·001 (t test)
Comparison of functional outcomes and quality of life in patients with Hirschsprung's disease
| Constipation (Rome IV criteria) | Faecal incontinence (Rome IV criteria) | |||||
|---|---|---|---|---|---|---|
| No | Yes |
| No | Yes |
| |
| CHQ‐CF87 score ( | ||||||
| Behaviour | 82 (21–99) | 76 (46–97) | 0·010 | 83 (61–99) | 77 (21–98) | 0·010 |
| Mental health | 81 (50–100) | 76 (42–97) | 0·021 | 81 (42–100) | 77 (50–100) | 0·056 |
| Self‐esteem | 77 (30–100) | 73 (41–100) | 0·013 | 75 (41–100) | 77 (30–100) | 0·877 |
| General health | 80 (21–100) | 69 (19–99) | 0·004 | 81 (19–100) | 74 (26–100) | 0·017 |
| WHOQOL‐100 score ( | ||||||
| Overall QoL | 16 (10–20) | 16 (7–20) | 0·055 | 16 (9–20) | 16 (7–20) | 0·319 |
| Physical health | 16 (8–20) | 15 (7–20) | 0·077 | 16 (10–20) | 15 (7–20) | 0·018 |
| Psychological health | 16 (10–20) | 15 (10–19) | 0·025 | 16 (10–20) | 15 (10–20) | 0·204 |
| Social relationships | 16 (9–20) | 15 (9–19) | 0·079 | 16 (9–20) | 16 (9–20) | 0·141 |
Values are median (range). CHQ‐CF87, Child Health Questionnaire Child Form; WHOQOL‐100, WHO Quality of Life questionnaire. QoL, quality of life.
Mann–Whitney U test.